Breaking News

RotaChrom Technologies Partners with Cyclolab

Aims to develop a more efficient and cost-effective process to purify Remdesivir, a widely used treatment option for COVID-19.

Author Image

By: Charlie Sternberg

Associate Editor

RotaChrom Technologies, the developer of an industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, has launched a collaboration with Cyclolab Cyclodextrin Research and Development Laboratory Ltd. This strategic partnership between Cyclolab and RotaChrom aims to develop a more efficient and cost-effective process to purify Remdesivir, which is a widely used treatment option for COVID-19.   Remdesivir, an inhibitor of the viral RNA-dependent, RNA polymerase, is a direct-a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters